Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cycloserine"" wg kryterium: Temat


Tytuł :
The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.
Autorzy :
Aye SZ; Department of Paediatrics and Child Health, Quest International University Perak, Ipoh, Malaysia.
Ni H; Department of Medicine, Newcastle University Medicine Malaysia, Johor, Malaysia.
Sein HH; Department of Paediatrics and Child Health, Quest International University Perak, Ipoh, Malaysia.
Mon ST; Department of Paediatrics, Newcastle University Medicine Malaysia, Johor, Malaysia.
Zheng Q; Department of Epidemiology, Singapore Clinical Research Institute, Singapore, Singapore.
Wong YKY; Cochrane Singapore, Singapore, Singapore.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 Feb 14; Vol. 2. Cochrane AN: CD013457. Date of Electronic Publication: 2021 Feb 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Communication*
Social Skills*
Autism Spectrum Disorder/*drug therapy
Cycloserine/*therapeutic use
Child ; Child, Preschool ; Cycloserine/adverse effects ; Female ; Humans ; Indiana ; Male ; Multicenter Studies as Topic ; Ohio ; Patient Dropouts/statistics & numerical data ; Placebos/therapeutic use ; Randomized Controlled Trials as Topic ; Stereotyped Behavior/drug effects
Czasopismo naukowe
Tytuł :
D-cycloserine augmentation of cognitive behavioral therapy for delusions: A randomized clinical trial.
Autorzy :
Diminich ED; Program in Public Health and the Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, NY, United States of America.
Dickerson F; Sheppard Pratt Health System, Baltimore, MD, United States of America.
Bello I; New York State Psychiatric Institute, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States of America.
Cather C; Massachusetts General Hospital, Boston, MA, United States of America.
Kingdon D; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Rakhshan Rouhakhtar PJ; Human Services Psychology Department, University of Maryland Baltimore County, Baltimore, MD, United States of America.
Hart KL; Department of Psychiatry, NYU Langone Health, New York, NY, United States of America.
Li C; Department of Population Health, Division of Biostatistics, NYU School of Medicine, New York, NY, United States of America.
Troxel AB; Department of Population Health, Division of Biostatistics, NYU School of Medicine, New York, NY, United States of America.
Goff DC; Department of Psychiatry, NYU Langone Health, New York, NY, United States of America; Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Schizophrenia research [Schizophr Res] 2020 Aug; Vol. 222, pp. 145-152. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Antimetabolites*/therapeutic use
Cognitive Behavioral Therapy*
Cycloserine*/therapeutic use
Delusions*/therapy
Adult ; Combined Modality Therapy ; Double-Blind Method ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Autorzy :
Kvale G; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Psychology, University of Bergen, Bergen, Norway.
Hansen B; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.; Center for Crisis Psychology, University of Bergen, Bergen, Norway.
Hagen K; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.; Department of Psychiatry, Molde Hospital, Molde, Norway.
Abramowitz JS; Department of Psychology and Neuroscience, University of North Carolina, Chapel Hill.
Børtveit T; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
Craske MG; Department of Psychology, University of California, Los Angeles.
Franklin ME; Rogers Memorial Hospital, Oconomowoc, Wisconsin.; Department of Psychology, University of Pennsylvania, Philadelphia.
Haseth S; Nidaros Outpatient Psychiatric Unit, St. Olavs Hospital, Trondheim, Norway.
Himle JA; School of Social Work, Department of Psychiatry, University of Michigan, Ann Arbor.
Hystad S; Department for Psychosocial Science, University of Bergen, Bergen, Norway.
Kristensen UB; Gaustad Hospital, Oslo University Hospital, Oslo, Norway.
Launes G; Solvang Outpatient Psychiatric Unit, Sørlandet Hospital, Kristiansand, Norway.
Lund A; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, Section for Psychiatry, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.
Solem S; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.; Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway.
Öst LG; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.; Department of Psychology, Stockholm University, Stockholm, Sweden.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2020 Aug 03; Vol. 3 (8), pp. e2013249. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Anxiety Agents/*therapeutic use
Cycloserine/*therapeutic use
Implosive Therapy/*methods
Obsessive-Compulsive Disorder/*therapy
Adult ; Anti-Anxiety Agents/adverse effects ; Cycloserine/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Obsessive-Compulsive Disorder/diagnosis ; Obsessive-Compulsive Disorder/psychology ; Patient Satisfaction ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
Autorzy :
Smits JAJ; Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin.
Pollack MH; Department of Psychiatry, Rush University Medical Center, Chicago, Illinois.; Now with Myriad Genetics, Salt Lake City, Utah.
Rosenfield D; Department of Psychology, Southern Methodist University, Dallas, Texas.
Otto MW; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.
Dowd S; Department of Psychiatry, Rush University Medical Center, Chicago, Illinois.
Carpenter J; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.
Dutcher CD; Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin.
Lewis EM; Department of Psychiatry, Rush University Medical Center, Chicago, Illinois.; Department of Psychology, Louisiana State University, Baton Rouge.
Witcraft SM; Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin.; Department of Psychology, University of Mississippi, Oxford.
Papini S; Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin.
Curtiss J; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.
Andrews L; Department of Psychology, Southern Methodist University, Dallas, Texas.; Department of Psychological and Brain Sciences, University of Delaware, Newark.
Kind S; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.; Department of Psychology, Suffolk University, Boston, Massachusetts.
Conroy K; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.; Department of Psychology, Florida International University, Coral Gables.
Hofmann SG; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2020 Jun 01; Vol. 3 (6), pp. e206777. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Antibiotics, Antitubercular/*administration & dosage
Cycloserine/*administration & dosage
Implosive Therapy/*methods
Phobia, Social/*drug therapy
Adult ; Antibiotics, Antitubercular/therapeutic use ; Case-Control Studies ; Cycloserine/therapeutic use ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Male ; Phobia, Social/psychology ; Phobia, Social/therapy ; Placebos/administration & dosage ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
D-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition.
Autorzy :
de Chiara C; Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London, UK.
Homšak M; Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London, UK.; Department of Chemistry, Imperial College London, The Molecular Sciences Research Hub, London, UK.
Prosser GA; Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.
Douglas HL; Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London, UK.
Garza-Garcia A; Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London, UK.
Kelly G; MRC Biomedical NMR Centre, The Francis Crick Institute, London, UK.
Purkiss AG; Structural Biology Science Technology Platform, The Francis Crick Institute, London, UK.
Tate EW; Department of Chemistry, Imperial College London, The Molecular Sciences Research Hub, London, UK.; Chemical Biology Satellite Laboratory, The Francis Crick Institute, London, UK.
de Carvalho LPS; Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London, UK. .
Pokaż więcej
Źródło :
Nature chemical biology [Nat Chem Biol] 2020 Jun; Vol. 16 (6), pp. 686-694. Date of Electronic Publication: 2020 Mar 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Alanine Racemase/*metabolism
Antibiotics, Antitubercular/*chemistry
Cycloserine/*chemistry
Recombinant Proteins/*metabolism
Alanine/chemistry ; Alanine/metabolism ; Alanine Racemase/genetics ; Amino Acid Sequence ; Antibiotics, Antitubercular/metabolism ; Bacterial Proteins/metabolism ; Binding Sites ; Cycloserine/metabolism ; Escherichia coli ; Isoxazoles/chemistry ; Ligases/metabolism ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/enzymology ; Oximes/chemistry ; Protein Binding ; Protein Conformation ; Recombinant Proteins/genetics
Czasopismo naukowe
Tytuł :
d-Cycloserine reverses scopolamine-induced object and place memory deficits in a spontaneous recognition paradigm in rats.
Autorzy :
Ozawa T; Institute of Psychology and Behavioral Neuroscience, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan.
Yamada K; Institute of Psychology and Behavioral Neuroscience, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan.
Ichitani Y; Institute of Psychology and Behavioral Neuroscience, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan. Electronic address: .
Pokaż więcej
Źródło :
Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 2019 Dec; Vol. 187, pp. 172798. Date of Electronic Publication: 2019 Oct 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cycloserine/*pharmacology
Memory Disorders/*chemically induced
Muscarinic Antagonists/*pharmacology
Receptors, N-Methyl-D-Aspartate/*agonists
Recognition, Psychology/*drug effects
Scopolamine/*pharmacology
Animals ; Behavior, Animal/drug effects ; Cycloserine/administration & dosage ; Cycloserine/therapeutic use ; Exploratory Behavior/drug effects ; Male ; Memory Disorders/drug therapy ; Muscarinic Antagonists/administration & dosage ; Muscarinic Antagonists/adverse effects ; Rats ; Rats, Wistar ; Scopolamine/administration & dosage ; Scopolamine/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Enhanced exposure therapy for combat-related Posttraumatic Stress Disorder (PTSD): Study protocol for a randomized controlled trial.
Autorzy :
Difede J; Department of Psychiatry, Weill Cornell Medical College, 525 East 68(th) Street, New York, NY 10065, United States. Electronic address: .
Rothbaum BO; Emory University School of Medicine, 12 Executive Pard Drive, Atlanta, GA 30329, United States.
Rizzo AA; University of Southern California Institute for Creative Technologies, 12015 East Waterfront Drive, Los Angeles, CA 90094, United States.
Wyka K; Department of Psychiatry, Weill Cornell Medical College, 525 East 68(th) Street, New York, NY 10065, United States.
Spielman L; Department of Psychiatry, Weill Cornell Medical College, 525 East 68(th) Street, New York, NY 10065, United States.
Jovanovic T; Emory University School of Medicine, 12 Executive Pard Drive, Atlanta, GA 30329, United States.
Reist C; Department of Research, Long Beach VA Medical Center, 5901 East 7(th) Street, Long Beach, CA 90822, United States.
Roy MJ; Department of Medicine and Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.
Norrholm SD; Emory University School of Medicine, 12 Executive Pard Drive, Atlanta, GA 30329, United States.
Glatt C; Department of Psychiatry, Weill Cornell Medical College, 525 East 68(th) Street, New York, NY 10065, United States.
Lee F; Department of Psychiatry, Weill Cornell Medical College, 525 East 68(th) Street, New York, NY 10065, United States.
Pokaż więcej
Źródło :
Contemporary clinical trials [Contemp Clin Trials] 2019 Dec; Vol. 87, pp. 105857. Date of Electronic Publication: 2019 Oct 24.
Typ publikacji :
Clinical Trial Protocol; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Cycloserine/*therapeutic use
Implosive Therapy/*methods
Stress Disorders, Post-Traumatic/*therapy
Veterans/*psychology
Virtual Reality Exposure Therapy/*methods
Combined Modality Therapy ; Cycloserine/administration & dosage ; Humans ; Stress Disorders, Post-Traumatic/genetics
Czasopismo naukowe
Tytuł :
The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG.
Autorzy :
Cahill C; TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, 8 Dublin, Ireland.
O'Connell F; Department of Surgery, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, 8 Dublin, Ireland.
Gogan KM; TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, 8 Dublin, Ireland.
Cox DJ; TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, 8 Dublin, Ireland.
Basdeo SA; TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, 8 Dublin, Ireland.
O'Sullivan J; Department of Surgery, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, 8 Dublin, Ireland.
Gordon SV; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, 4 Dublin, Ireland.
Keane J; TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, 8 Dublin, Ireland.
Phelan JJ; TB Immunology Group, Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, St James's Hospital, 8 Dublin, Ireland.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 13; Vol. 22 (6). Date of Electronic Publication: 2021 Mar 13.
Typ publikacji :
Journal Article
MeSH Terms :
Antitubercular Agents/*pharmacology
Deferoxamine/*pharmacology
Diarylquinolines/*pharmacology
Iron/*metabolism
Iron Chelating Agents/*pharmacology
Macrophages/*drug effects
Mycobacterium bovis/*drug effects
Amikacin/pharmacology ; Bacterial Load/drug effects ; Cell Survival/drug effects ; Clofazimine/pharmacology ; Cycloserine/pharmacology ; Drug Resistance, Bacterial/drug effects ; Drug Synergism ; Gene Expression ; Humans ; Interferon-gamma/genetics ; Interferon-gamma/immunology ; Interleukin-1beta/genetics ; Interleukin-1beta/immunology ; Interleukin-6/genetics ; Interleukin-6/immunology ; Linezolid/pharmacology ; Macrophages/immunology ; Macrophages/microbiology ; Microbial Sensitivity Tests ; Moxifloxacin/pharmacology ; Mycobacterium bovis/growth & development ; Mycobacterium bovis/metabolism ; Primary Cell Culture ; Pyrazinamide/pharmacology
Czasopismo naukowe
Tytuł :
Isolated multidrug-resistant tubercular tenosynovitis of the flexor tendon of the little finger.
Autorzy :
Chaudhary S; Department of Orthopedics, All India Institute of Medical Sciences - Rishikesh, Rishikesh, India .
Maji S; Department of Orthopedics, All India Institute of Medical Sciences - Rishikesh, Rishikesh, India.
Garg V; Department of Orthopedics, All India Institute of Medical Sciences - Rishikesh, Rishikesh, India.
Singh V; Department of Orthopedics, All India Institute of Medical Sciences - Rishikesh, Rishikesh, India.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Feb 19; Vol. 14 (2). Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Drug Resistance, Multiple/*drug effects
Fingers/*diagnostic imaging
Magnetic Resonance Imaging/*methods
Tenosynovitis/*diagnostic imaging
Tuberculosis/*complications
Tuberculosis/*drug therapy
Adult ; Anti-Bacterial Agents/therapeutic use ; Anti-Inflammatory Agents/therapeutic use ; Antitubercular Agents/therapeutic use ; Clofazimine/therapeutic use ; Cycloserine/therapeutic use ; Diagnosis, Differential ; Ethambutol/therapeutic use ; Female ; Fingers/surgery ; Humans ; Levofloxacin/therapeutic use ; Linezolid/therapeutic use ; Tendons/diagnostic imaging ; Tenosynovitis/etiology ; Tenosynovitis/surgery ; Young Adult
Czasopismo naukowe
Tytuł :
Development and validation of bioanalytical method for quantification of cycloserine in human plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study.
Autorzy :
Dodda S; Department of Pharmacy, Anurag group of Institutions (Formerly Lalitha College of Pharmacy), Hyderabad, India.; Department of pharmaceutical Sciences, IST, Jawaharlal Nehru Technological University, Hyderabad, India.
Makula A; Department of pharmaceutical Sciences, IST, Jawaharlal Nehru Technological University, Hyderabad, India.
Kandhagatla RN; Biotechnica Pharma, Hyderabad, India.
Pokaż więcej
Źródło :
Biomedical chromatography : BMC [Biomed Chromatogr] 2019 Aug; Vol. 33 (8), pp. e4548. Date of Electronic Publication: 2019 May 02.
Typ publikacji :
Journal Article
MeSH Terms :
Chromatography, High Pressure Liquid/*methods
Cycloserine/*blood
Cycloserine/*pharmacokinetics
Solid Phase Extraction/*methods
Tandem Mass Spectrometry/*methods
Cycloserine/chemistry ; Humans ; Limit of Detection ; Linear Models ; Male ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us.
Autorzy :
Intini E; Division of Respiratory Medicine, A Gemelli University Hospital, Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy .; Department of Respiratory Medicine, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Kishore G; Department of Respiratory Medicine, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Richeldi L; Division of Respiratory Medicine, A Gemelli University Hospital, Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome, Italy.
Udwadia ZF; Department of Respiratory Medicine, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2019 Dec 04; Vol. 12 (12). Date of Electronic Publication: 2019 Dec 04.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antitubercular Agents/*adverse effects
Cycloserine/*adverse effects
Depression/*chemically induced
Tuberculosis, Multidrug-Resistant/*drug therapy
Antitubercular Agents/therapeutic use ; Cycloserine/therapeutic use ; Female ; Humans ; India ; Middle Aged ; Suicide, Attempted
Czasopismo naukowe
Tytuł :
Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.
Autorzy :
Chen MH; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan.
Cheng CM; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Yuanshan branch, Taipei Veterans General Hospital, Yilan, Taiwan.
Gueorguieva R; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.; Department of Biostatistics, School of Public Health, Yale University, New Haven, CT, USA.
Lin WC; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan.
Li CT; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan.
Hong CJ; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan.
Tu PC; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
Bai YM; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan.
Tsai SJ; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan.
Krystal JH; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. .; Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA. .; Yale-New Haven Hospital, New Haven, CT, USA. .; VA National Center for PTSD, VA Connecticut Healthcare System, West Haven, CT, USA. .
Su TP; Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan. .; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan. .; Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan. .; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan. .; Department of Psychiatry, Cheng Hsin General Hospital, Taipei, Taiwan. .
Pokaż więcej
Źródło :
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2019 Nov; Vol. 44 (12), pp. 2112-2118. Date of Electronic Publication: 2019 Aug 17.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antidepressive Agents/*therapeutic use
Bipolar Disorder/*drug therapy
Cycloserine/*therapeutic use
Depressive Disorder, Major/*drug therapy
Depressive Disorder, Treatment-Resistant/*drug therapy
Ketamine/*therapeutic use
Suicide/*prevention & control
Adult ; Cycloserine/analogs & derivatives ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Genomic Triplication of the Glycine Decarboxylase Gene and N-Methyl-D-Aspartate Receptor Hypofunction: Improvement by Glycine and D-Cycloserine.
Autorzy :
Hashimoto K; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan. Electronic address: .
Pokaż więcej
Źródło :
Biological psychiatry [Biol Psychiatry] 2019 Oct 01; Vol. 86 (7), pp. 497-498.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Cycloserine*
Psychotic Disorders*
DNA Copy Number Variations ; Genomics ; Glycine ; Glycine Dehydrogenase (Decarboxylating) ; Humans ; Receptors, N-Methyl-D-Aspartate
Czasopismo naukowe
Tytuł :
Steady-state population pharmacokinetics of terizidone and its metabolite cycloserine in patients with drug-resistant tuberculosis.
Autorzy :
Mulubwa M; School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa.
Mugabo P; School of Pharmacy, University of the Western Cape, Bellville, Cape Town, South Africa.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Sep; Vol. 85 (9), pp. 1946-1956. Date of Electronic Publication: 2019 Jul 12.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Models, Biological*
Antibiotics, Antitubercular/*pharmacokinetics
Cycloserine/*pharmacokinetics
Isoxazoles/*pharmacokinetics
Oxazolidinones/*pharmacokinetics
Tuberculosis, Multidrug-Resistant/*drug therapy
Adolescent ; Adult ; Antibiotics, Antitubercular/administration & dosage ; Cycloserine/administration & dosage ; Female ; Humans ; Isoxazoles/administration & dosage ; Male ; Middle Aged ; Oxazolidinones/administration & dosage ; Serum Albumin, Human/analysis ; South Africa ; Tuberculosis, Multidrug-Resistant/blood ; Young Adult
Czasopismo naukowe
Tytuł :
Sensitive Ultra-performance Liquid Chromatography Tandem Mass Spectrometry Method for Determination of Cycloserine in Plasma for a Pharmacokinetics Study.
Autorzy :
Mulubwa M; School of Pharmacy, University of the Western Cape, Private Bag X17, Bellville 7535, Cape Town, South Africa.
Mugabo P; School of Pharmacy, University of the Western Cape, Private Bag X17, Bellville 7535, Cape Town, South Africa.
Pokaż więcej
Źródło :
Journal of chromatographic science [J Chromatogr Sci] 2019 Jul 01; Vol. 57 (6), pp. 560-564.
Typ publikacji :
Journal Article
MeSH Terms :
Chromatography, High Pressure Liquid/*methods
Cycloserine/*blood
Tandem Mass Spectrometry/*methods
Antibiotics, Antitubercular/blood ; Antibiotics, Antitubercular/chemistry ; Antibiotics, Antitubercular/pharmacokinetics ; Antibiotics, Antitubercular/therapeutic use ; Cycloserine/chemistry ; Cycloserine/pharmacokinetics ; Cycloserine/therapeutic use ; Humans ; Limit of Detection ; Linear Models ; Reproducibility of Results ; Tuberculosis, Multidrug-Resistant/drug therapy
Czasopismo naukowe
Tytuł :
Preclinical Development of Inhalable d-Cycloserine and Ethionamide To Overcome Pharmacokinetic Interaction and Enhance Efficacy against Mycobacterium tuberculosis .
Autorzy :
Ranjan R; CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.; Academy of Scientific and Innovative Research, CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.
Srivastava A; CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.; Academy of Scientific and Innovative Research, CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.
Bharti R; CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.
Roy T; CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.; Academy of Scientific and Innovative Research, CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.
Verma S; CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.
Ray L; CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India.
Misra A; CSIR-Central Drug Research Institute, Janakipuram Extension, Lucknow, India .
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 May 24; Vol. 63 (6). Date of Electronic Publication: 2019 May 24 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antitubercular Agents/*pharmacokinetics
Cycloserine/*pharmacokinetics
Ethionamide/*pharmacokinetics
Mycobacterium tuberculosis/*drug effects
Tuberculosis, Pulmonary/*drug therapy
Administration, Inhalation ; Administration, Oral ; Animals ; Antitubercular Agents/administration & dosage ; Cycloserine/administration & dosage ; Drug Resistance, Bacterial ; Ethionamide/administration & dosage ; Lung/microbiology ; Mice ; Tuberculosis, Pulmonary/microbiology
Czasopismo naukowe
Tytuł :
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
Autorzy :
Alghamdi WA; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, USA.; Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Alsultan A; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Al-Shaer MH; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
An G; Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, USA.
Ahmed S; Infectious Diseases Division, International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Alkabab Y; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Banu S; Infectious Diseases Division, International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Barbakadze K; National Center for TB and Lung Diseases (NCTLD), Tbilisi, Georgia.
Houpt E; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Kipiani M; National Center for TB and Lung Diseases (NCTLD), Tbilisi, Georgia.
Mikiashvili L; National Center for TB and Lung Diseases (NCTLD), Tbilisi, Georgia.
Schmidt S; Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA.
Heysell SK; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Kempker RR; Division of Infectious Diseases, Department of Medicine, Emory University, Atlanta, Georgia, USA.
Cegielski JP; University of Texas Health Science Center at Tyler, Tyler, Texas, USA.
Peloquin CA; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, USA .
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 Apr 25; Vol. 63 (5). Date of Electronic Publication: 2019 Apr 25 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*pharmacokinetics
Cycloserine/*pharmacokinetics
Tuberculosis/*drug therapy
Anti-Bacterial Agents/therapeutic use ; Cycloserine/therapeutic use ; Humans ; Microbial Sensitivity Tests ; Monte Carlo Method ; Tuberculosis/metabolism ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/metabolism
Czasopismo naukowe
Tytuł :
Integron gene cassettes harboring novel variants of D-alanine-D-alanine ligase confer high-level resistance to D-cycloserine.
Autorzy :
Rahman MA; Department of Microbial Diseases, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK.; Department of Pharmacy, University of Rajshahi, Rajshahi, 6205, Bangladesh.
Kaiser F; Department of Microbial Diseases, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK.
Jamshidi S; School of Cancer and Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Freitas Monteiro M; Department of Microbial Diseases, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK.; Division of Immunology and Allergology, University Hospitals and Medical Faculty, Geneva, Switzerland.
Rahman KM; School of Cancer and Pharmaceutical Science, King's College London, London, SE1 9NH, UK.
Mullany P; Department of Microbial Diseases, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK.
Roberts AP; Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK. .; Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Nov 26; Vol. 10 (1), pp. 20709. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cycloserine/*pharmacology
Drug Resistance, Bacterial/*genetics
Integrons/*genetics
Peptide Synthases/*genetics
Anti-Bacterial Agents/pharmacology ; Escherichia coli/drug effects ; Humans ; Molecular Docking Simulation ; Treponema denticola/drug effects
Czasopismo naukowe
Tytuł :
D-Cycloserine Improves Difficult Discriminations in a Pattern Separation Task in Alzheimer's Disease Patients with Dementia.
Autorzy :
Goetghebeur PJD; Bracket LLC, Reading, UK.
Wesnes KA; Wesnes Cognition Ltd, Streatley on Thames, UK.; Medical School, University of Exeter, Exeter, UK.; Department of Psychology, Northumbria University, Newcastle, UK.; Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia.
Targum SD; Bracket LLC, Boston, MA, USA.
Pokaż więcej
Źródło :
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2019; Vol. 69 (2), pp. 377-383.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Alzheimer Disease/*drug therapy
Alzheimer Disease/*psychology
Cycloserine/*therapeutic use
Pattern Recognition, Visual/*physiology
Psychomotor Performance/*physiology
Aged ; Aged, 80 and over ; Antimetabolites/pharmacology ; Antimetabolites/therapeutic use ; Cycloserine/pharmacology ; Dementia/drug therapy ; Dementia/psychology ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Pattern Recognition, Visual/drug effects ; Photic Stimulation/methods ; Psychomotor Performance/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies